ReCerf Receives CE Mark: A Milestone for Ceramic Hip Resurfacing in Europe

Exciting Development in Hip Resurfacing: ReCerf Achieves CE Mark

On July 3, 2025, MatOrtho announced a significant advancement in orthopedic surgery with the CE mark approval of their innovative ReCerf Hip Resurfacing Arthroplasty (HRA). This certification confirms the device's adherence to stringent European safety and performance standards. With this milestone, the accessibility of ceramic hip resurfacing is set to expand not only across the UK and Europe but also in international markets that recognize CE marking.

Mike Tuke, the founder of MatOrtho, underscored the importance of this achievement, stating, "This is more than a regulatory milestone; it signifies two decades of dedicated efforts towards improving hip resurfacing with advanced materials." The collaboration with CeramTec A.G. led to the creation of ReCerf, an all-ceramic resurfacing implant designed to improve patient outcomes. The device has already garnered positive results since its launch and is available to specialized surgeons aiming to provide their patients with dependable options to maintain an active lifestyle.

The ReCerf system is the first commercially available ceramic hip resurfacing device, initially approved by Australia’s Therapeutic Goods Administration in November 2024. Since evolving into clinical practice in 2018, more than 1,600 patients have successfully undergone the procedure, benefitting from what has been reported as excellent patient-reported outcomes and an impressively low revision rate extending up to six years.

What sets ReCerf apart is its composition, which utilizes BIOLOX® delta ceramic. This material eliminates many of the risks historically associated with metal-on-metal bearings, while also preserving more of the patient's natural bone structure during the surgical process. For surgeons, ReCerf presents a familiar operational framework enhanced by the latest material innovations. MatOrtho's credentials as pioneers in the field of hip resurfacing bolster the trust placed in this new solution.

Accompanying the product's launch is MatOrtho’s commitment to responsible use. The company emphasizes structured education for surgeons, thorough patient selection for surgeries, and continuous clinical monitoring. Already, they have initiated a peer-led surgeon training program to ensure the safe and effective implementation of this groundbreaking device across medical settings.

With the introduction of ReCerf, MatOrtho looks not only to strengthen its strategic presence in the orthopedic market but also to reaffirm its leadership status in delivering innovative orthopedic solutions that help restore normal joint functions and allow individuals to return to high levels of physical activity.

For those interested in learning more about this innovative solution and its significance within orthopedic practices, visit ReCerf's Official Website.

About MatOrtho

MatOrtho (formerly Finsbury Orthopaedics) has established itself as a global leader in orthopedic innovation. They are dedicated to advancing joint replacement technologies aimed at enhancing patient outcomes and setting higher clinical benchmarks in the industry. For comprehensive information, explore their website at MatOrtho Official.